Atlas Trials

Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma

Clinical trial NCT03633734 · UNKNOWN

Trial details

NCT number
NCT03633734
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Adenocarcinoma MetastaticChemotherapy Effect
Start date
2018-07-01
Primary completion
2023-08-31
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.